Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation
-
- Masanobu Fujimoto
- Division of Endocrinology, Cincinnati Center for Growth Disorders, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
-
- Melissa Andrew
- Division of Endocrinology, Cincinnati Center for Growth Disorders, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
-
- Lihong Liao
- Division of Endocrinology, Cincinnati Center for Growth Disorders, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
-
- Dongsheng Zhang
- Division of Endocrinology, Cincinnati Center for Growth Disorders, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
-
- Gozde Yildirim
- Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, New York
-
- Patrick Sluss
- Ansh Laboratories, Webster, Texas
-
- Bhanu Kalra
- Ansh Laboratories, Webster, Texas
-
- Ajay Kumar
- Ansh Laboratories, Webster, Texas
-
- Shoshana Yakar
- Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, New York
-
- Vivian Hwa
- Division of Endocrinology, Cincinnati Center for Growth Disorders, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
-
- Andrew Dauber
- Division of Endocrinology, Cincinnati Center for Growth Disorders, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
収録刊行物
-
- Endocrinology
-
Endocrinology 160 (6), 1363-1376, 2019-04-12
The Endocrine Society
